Results 61 to 70 of about 227,175 (284)
Medicines and hospitals brazilian health system: the impact of pharmacy and therapeutics committees
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2018 This study aimed to analyze the economic and access impact, beyond the levels of essential drug lists of public hospitals after the establishment of Pharmacy and Therapeutics (P&T) committees.
Rafael Santos Santana +4 more
doaj +1 more source
A comparison of national essential medicines lists in the Americas
Revista Panamericana de Salud Pública, 2020 Objectives. To compare national essential medicines lists (NEMLs) from countries in the Region of the Americas and to identify potential opportunities for improving those lists. Methods.
Liane Steiner +7 more
doaj +1 more source
Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe [PDF]
, 2018 International ...
Gandra, S +6 more
core +3 more sources
Indian Essential Medicine List for Children: Time to Revisit.
Cureus, 2023 The majority of the under five mortality rate (U5MR) in India were due to treatable causes and could have been prevented by providing quality medicines. Availability and affordability of medicine can be improved by the introduction of essential medicine concepts.The current study was carried out to compare the latest edition of the WHO essential ...
Singhal, Shubha +3 more
openaire +2 more sources
Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma
Pediatric Blood &Cancer, EarlyView.ABSTRACT Approximately 10% of patients with Ewing sarcoma (EwS) have pathogenic germline variants. Here, we report two cases: first, a novel germline pathogenic variant in partner and localizer of BRCA2 (PALB2) in a patient with a late EwS relapse. Its impact on homologous recombination is demonstrated, and breast cancer risk is discussed.
Molly Mack +12 more
wiley +1 more source
Preliminary Report on Patent Literature, Search Methodology and Patent Status of Medicines on the WHO EML 2009 [PDF]
, 2011 Over the past several decades the World Health Organization (WHO) has produced the Essential Medicines List (EML) to assist countries in deciding what medicines should be essential and available in National Essential Medicine Lists.1 WHO, through the ...
Cavicchi, Jon R., Kowalski, Stanley P.
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Despite their increased risk for functional impairment resulting from cancer and its treatments, few adolescents and young adults (AYAs) with a hematological malignancy receive the recommended or therapeutic dose of exercise per week during inpatient hospitalizations.
Jennifer A. Kelleher +8 more
wiley +1 more source
Frontiers in Pharmacology, 2020 Every two years, the World Health Organization (WHO) updates its Model List of Essential Medicines, intended as a guide for countries to adopt or adapt in accordance with local priorities and treatment guidelines, for the development of national ...
Bernadette Cappello +4 more
doaj +1 more source
Access and use of WHO essential medicines in Italy
Frontiers in Public Health, 2023 BackgroundMany countries use the WHO Essential Medicines List (EML) as a guide for health policy choices to promote the efficient use of healthcare resources or adopt the concept of essential medicines (EMs) to develop their own national list of ...
Alessandro Petrella +4 more
doaj +1 more source
Pharmacogenomic testing and its future in community pharmacy [PDF]
, 2020 Although it is common to see pharmacogenomic testing used North America and Australia, it is not yet part of practice in the UK. With the promise of genomic screening becoming part of the NHS, pharmacists must equip themselves with a knowledge of how the
Wright, David, Youssef, Essra
core +1 more source